PHAR Competitors & Alternatives
Compare Pharming Group NV with similar stocks in the same industry
Biotechnology
PHAR
Main Stock$10.67
Tradestie Score
40
Market Cap
$1.05B
P/E Ratio
74.2
Revenue Growth
0.0%
Analyst Upside
+221.9%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
ANL
ANL
|
$10.58
|
$725.12M | - | 69 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$25.51
|
$718.62M | 10.7 | 29 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$20.87
|
$715.25M | - | 50 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$126.39
|
$699.30M | - | 68 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$5.86
|
$688.47M | - | 52 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.77
|
$665.30M | 11.3 | 57 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.04
|
$626.91M | - | 45 | Compare |
More PHAR Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry